Europe Investigates Reports of Blood Clots in Recipients of J&J’s Covid-19 Vaccine

The European Union’s health and fitness company is investigating a smaller number of reviews of severe blood clots among folks who have acquired the Johnson & Johnson Covid-19 vaccine.

There have been four claimed cases of major blood clots, such as a single demise, in folks who acquired the J&J vaccine, the European Medicines Agency said on Friday. One particular circumstance happened in a scientific trial and 3 were being in folks specified the shot as aspect of the U.S. vaccination campaign.

The EMA said it is not very clear but whether there is a link amongst the vaccine and the blood clots and that the company could make a decision to mandate an update to the protection facts integrated with the vaccine. Very last month, the EMA permitted the J&J vaccine—which is branded as Janssen, a J&J unit— for use in the EU, but the rollout is not expected to get started until later on this month.

“Our close monitoring of facet outcomes has disclosed a smaller number of really uncommon gatherings pursuing vaccination,” J&J said. “At current, no clear causal relationship has been founded amongst these uncommon gatherings and the Janssen Covid-19 vaccine.”

The scrutiny follows weeks of investigation into whether the Covid-19 vaccine co-formulated by AstraZeneca PLC is connected to uncommon blood-clotting conditions. The two companies’ vaccines are centered on similar science.